Reflect on your last visit to a healthcare provider. Did you feel like a valued partner in your care? Now, consider participating in a research study with an unapproved potential treatment. How has ...
Alcami Corp., a contract development and manufacturing organization (CDMO) headquartered in Durham and with major operations in Wilmington, has expanded its drug-making capacity by acquiring TriPharm ...
Bamboo Therapeutics, a next-generation gene therapy company based in Chapel Hill, has been acquired by the pharmaceutical giant Pfizer of New York. Pfizer, which had acquired a 22 percent stake in ...
Charles E. Hamner, Jr., Ph.D., a former president and CEO of the North Carolina Biotechnology Center and a longtime advocate for life sciences in the state, has received the 2024 High Flyer Champion ...
Many facilities across North Carolina support life sciences research. The listing covers core laboratory facilities at university and nonprofit research institutions that are open to researchers or ...
There’s a new biotech company setting up shop in the Triangle, and it’s flush with cash and headed up by some big names in the industry. Meet Kriya Therapeutics – the brainchild of Dr. Shankar ...
The rapid global march of the coronavirus that began in Wuhan, China several months ago could be slowed by researchers and biotech firms 7,770 miles away – in the Research Triangle of North Carolina.
The Toxicology Forum's mission is dedicated to fostering deliberative dialogue to shape decision-making and outcomes on critical issues in toxicology and its applications to promote and protect public ...
The North Carolina Biotechnology Center has announced the inaugural class of Pfizer-NCBiotech Distinguished Postdoctoral Fellows in Gene Therapy. The Fellows include Adrian Pickar and Hye Ri Kang of ...
$1.85B Expansion in Johnston County Doubling Workforce of 700 Collaborative Success for EDPNC, NCBiotech and State/Local Officials Each Biomanufacturing Job Creates Six Total Jobs Novo Nordisk, a key ...
Pancreatic cancer is an elusive and deadly disease. It often has no initial symptoms, and there are no reliable tests for early detection. The mortality rate is 75 percent within a year of diagnosis, ...
Chapel Hill bioscience company BioKier has leveraged early loan support from the North Carolina Biotechnology Center into a $1.7 million funding package. Broadview Ventures and the American Heart ...